Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis.

Lila E. Nachtigall, R. Nachtigall, Robert D. Nachtigall, Emma Beckman

PubMed · 1979 · 375 citations · 0 references

Concepts

TL;DR

The study aimed to evaluate the effects of estrogen replacement therapy over 10 years in postmenopausal women. Eighty‑four matched postmenopausal pairs were randomized to receive either conjugated estrogens with cyclic progesterone or placebo in a double‑blind design. Patients who began estrogen therapy within three years of menopause experienced no worsening of osteoporosis, whereas placebo controls showed increased bone loss.

Abstract

A 10-year, double-blind prospective study was undertaken to evaluate the effects of estrogen replacement therapy. The sample population consisted of 84 pairs of randomly chosen postmenopausal patients who were matched for age and diagnosis. One half of the patients received conjugated estrogens and cyclic progesterone, while the other half received placebo. Estrogen-treated patients whose therapy started within 3 years of menopause showed improvement or no increase in osteoporosis. Control patients demonstrate an increase in their osteoporosis.